• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
For: Gonzalez-Angulo AM, Krop I, Piha-Paul S, Li Y, Culotta KS, Moulder-Thompson S, Tsimberidou A, Velez-Bravo VM, Madden TL, Norberg LM, Doyle A, Winder EP, Mills GB, Meric-Bernstam F, Kurzrock R. Abstract LB-231: Phase Ib dose escalation and biomarker study of MK2206 in combination with standard doses of weekly paclitaxel in patients with locally advanced or metastatic solid tumors with expansion in advanced breast cancer. Clin Trials 2014. [DOI: 10.1158/1538-7445.am2012-lb-231] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Number Cited by Other Article(s)
1
Huemer F, Bartsch R, Gnant M. The PI3K/AKT/MTOR Signaling Pathway: The Role of PI3K and AKT Inhibitors in Breast Cancer. Curr Breast Cancer Rep 2014. [DOI: 10.1007/s12609-014-0139-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA